What is the Role of Biologics in UC?

Joanna K. Law, Brian Bressler

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The treatment of ulcerative colitis (UC) has traditionally involved 5-aminosalicylates, immunomodulators, and/or corticosteroid therapy along with surgical management. Recent studies have suggested that biologic therapy may have a role in the treatment of ulcerative colitis for patients with moderate to severely active colitis. In this chapter we review the role of biologics in the treatment of UC.

Original languageEnglish (US)
Title of host publicationClinical Dilemmas in Inflammatory Bowel Disease
Subtitle of host publicationNew Challenges: Second Edition
PublisherWiley-Blackwell
Pages120-123
Number of pages4
ISBN (Print)9781444334548
DOIs
StatePublished - Jan 30 2012

Keywords

  • Biologics
  • Infliximab
  • Ulcerative colitis

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'What is the Role of Biologics in UC?'. Together they form a unique fingerprint.

Cite this